XM does not provide services to residents of the United States of America.

British Business - Aug. 26



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>PRESS DIGEST-British Business - Aug. 26</title></head><body>

Aug 26 (Reuters) -The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.



The Times

- The British Financial Conduct Authority has warned unregulated firms that they cannot help to arrange investment deals for private companies without regulatory permissions.


- AstraZeneca Plc AZN.L, Unilever Plc ULVR.L and GSK Plc GSK.L are among large companies that have renewed membership of the CBI, 16 months after the organisation was shaken by claims of sexual misconduct by staff.


The Guardian

- Senior cabinet minister Pat McFadden has warned of more economic pain to come as the government prepares to restrict public spending in ways MPs and campaigners say could exacerbate the cost of living crisis.


- The business and trade secretary, Jonathan Reynolds, has signalled a new twin-track approach to UK trade policy, in which the Labour government will pursue closer ties with the European Union while at the same time seeking new global partnerships further afield.

The Telegraph

- Marks & Spencer is considering opening a range of clothing-only boutiques as soaring demand for its lingerie and cashmere jumpers help reverse years of decline in its fashion sales.


Sky News

- Dove soap maker Unilever Plc ULVR.L is trying to slim its portfolio of personal care brands by putting two of them up for sale.


- Telegram said its Chief Executive Pavel Durov has "nothing to hide" after he was arrested in France, adding the charges against him are "absurd".


The Independent

- UK Prime Minister Keir Starmer will warn the public that things will get worse before they get better in his first keynote speech since walking into Downing Street.



(Compiled by Bengaluru newsroom)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.